Newer uses of glucose-insulin-potassium regimen

Medical Science Monitor

Volumn 6, Issue 6, 2000, Pages 1053-1055

  Das, U N ^a  

^a EFA Sciences LLC   (United States)

Author keywords

Diabetes; GIK; Hyperglycemia; Ketoacidosis; Treatment

Indexed keywords

GLUCOSE; INSULIN; MACROPHAGE MIGRATION INHIBITION FACTOR; POTASSIUM; TUMOR NECROSIS FACTOR ALPHA;

CANCER; CROHN DISEASE; DIABETIC KETOACIDOSIS; DRUG EFFECT; DRUG INDICATION; DRUG MECHANISM; DRUG USE; HEART INFARCTION; HYPERGLYCEMIA; RHEUMATOID ARTHRITIS; SEPTIC SHOCK; SEPTICEMIA; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS;

ANIMALS; DIABETIC KETOACIDOSIS; GLUCOSE; HEART; HUMANS; INSULIN; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MODELS, BIOLOGICAL; MYOCARDIAL INFARCTION; POTASSIUM; SEPSIS; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034533171     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (22)

1. Metabolic modulation of acute myocardial infarction
2. Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion
3. Limiting ischemic myocardial damage using glucose-insulin-potassium solutions
4. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
5. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
6. Possible beneficial action(s) of glucose-insulin-potassium regimen in acute myocardial infarction and inflammatory conditions: A hypothesis
7. Therapeutic strategies to reduce TNF-alpha mediated cardiac contractile depression following ischemia and perfusion
8. Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction
9. Relationship of hypoglycemia to tumor necrosis factor production and antitumor activity: Role of glucose, insulin and macrophages
10. Reversal of the toxic effects of cachectin by concurrent insulin administration
11. Endotoxin-induced acute lung injury in rats. Role of insulin
12. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: A specific vascular action of insulin
13. Inhaled nitric oxide prevents IL-1 induced neutrophil accumulation and associated acute edema in isolated rat lungs
14. Protection from septicshock by neutralization of macrophage migration inhibitory factor
15. Tumor necrosis factor-alpha regulates the gene expression of macrophage migration inhibitory factor through tyrosine kinase-dependent pathway in 3T3-L1 adipocytes
16. Regulation of macrophage migration inhibitory factor (MIF) expression by glucose and insulin in adipocytes in vitro
17. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor
18. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
19. Treatment of ulcerative colitis with an engineered human anti-TNF alpha antibody CDP571
20. Anticytokine therapy in rheumatoid arthritis
21. Serum levels of tumor necrosis factor in squamous cell carcinoma of the head and neck
22. Reversal of weight loss induced by tumor necrosis factor-alpha